A Philadelphia negative chronic myelogenous leukemia with the chimeric BCR/ABL gene on chromosome 9 and a b3-a2 splice junction

Cancer Genetics and Cytogenetics

Volumn 101, Issue 2, 1998, Pages 143-147

  MacEra, Michael J ^a   Smith, Larry J ^a   Frankel, Etta ^b   Szabo, Paul ^c   Verma, Ram S ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CASE REPORT; CELL TRANSFORMATION; CHIMERA; CHROMOSOME 9Q; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE COURSE; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SPLICEOSOME;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 9; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 0032032923     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00257-4     Document Type: Article

References (33)

1. Heisterkamp N, Stam K, Groggen J, de Klein A, Grosveld G Structural organization of the bcr gene and its role in the Ph translocation. Nature. 315:1985;758-761.
2. Melo JV The molecular biology of chronic myeloid leukemia. Leukemia. 10:1996;751-756.
3. Morris CM, Reeve AE, Fitzgerald PH, Beard MEJ, Heaton DC Genomic diversity correlates with clinical variations in Ph-negative chronic myeloid leukemia. Nature. 320:1986;281-283.
4. Ganesan TS, Rassool F, Guo A-P, Th'ng KH, Dowding C, Hibbin JA, Young BD, White H, Kurmaran TO, Galton DAG, Goldman JM Rearrangement of the bcr gene in Philadelphia chromosome negative chronic myeloid leukemia. Blood. 68:1986;957-960.
5. Van der Plas DC, Hermans ABC, Soekareman D, Smit EME, de Klein A, Smadja N, Allemena G, Goldsmith R, Grosveld G, Hademeijer A Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 73:1989;1038-1044.
6. Inazawa J, Nishigaki H, Takashira H, Nishimura J, Horiike S, Taniwake M, Misawa S, Abe T Rejoining between 9q+ and Philadelphia chromosomes results in normal looking chromosomes 9 and 22 in Ph-negative chronic myelocytic leukemia. Hum Genet. 83:1989;115-118.
7. Rassool G, Martiat P, Taj A, Klisak I, Goldman J Interstitial insertion of varying amounts of ABL containing genetic material into chromosome 22 in Ph-negative CML. Leukemia. 4:1990;273-277.
8. Nacheva E, Holloway T, Brown K, Bloxham D, Green AR Philadelphia-negative chronic myeloid leukemia detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or 22. Br J Hematol. 87:1994;409-412.
9. Dube I, Dixon J, Beckett T, Gossman A, Weinstein M, Benn P, McKeithan T, Norman C, Pinkerton P Location of breakpoints within the major breakpoint cluster region (BCR) in 33 patients with bcr-rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes. Genes Chromosom Cancer. 1:1989;106-111.
10. Sokal JE, Baccarani M, Russo D, Tura S Staging and prognosis in chronic myelogenous leukemia. Semin Hematol. 25:1988;49-61.
11. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1991): Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. Ann Hematol 63:307-314.
12. 1-positive chronic myeloid leukemia? Leuk Lymphoma. 16:1995;231-236.
13. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers G, Van der Plass D, Grosveld G Translocation of BCR to chromosome 9. A new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia Genes Chromosom Cancer. 8:1993;237-245.
14. Abeliovich D, Yehuda O, Krichevsky S, Werner M, Ludkovsky O, Ben-Yehuda D Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia. Cancer Genet Cytogenet (. 1989):1995;81. 115-117.
15. Macera MJ, Szabo P, Verma RS A simple method for short term culturing bone marrow and unstimulated blood from acute leukemias. Leuk Res. 13:1989;729-734.
16. Verma RS, Babu A Human Chromosomes. Principles and Techniques:1995;McGraw-Hill, New York.
17. Etkind PR, Szabo P, Sarkai NH Restriction endonuclease mapping of the proviral DNA of the exogenous R111 murine mammary tumor virus. J Virol. 44:1982;855-867.
18. Chomczynski P, Sacchi N Single step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
19. Davis PL, Konopla JB, Witte ON Activation of the c-abl oncogene by viral transduction of chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol. 5:1985;204-213.
20. Kloetzer W, Kurzrock R, Smith L, Talpaz M, Spiller M, Getterman J, Arlinghaus R The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology. 140:1985;230-238.
21. Muller AJ, Young JC, Pendergast AM, Pondel M, Littman DR, Witte ON BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol. 11:1991;1785-1792.
22. Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON BCR sequences essential for transformation by the BCR/ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell. 66:1991;161-171.
23. Abe S, Minamihisamatsu M, Ishihara T, Sasaki M Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations. Cancer Genet Cytogenet. 38:1989;61-74.
24. 1-negative CML patient. EMBO J. 4:1985;683-686.
25. Calabrese G, Stuppia L, Franchi PG, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A, Palka G Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet. 78:1994;153-159.
26. Jadayel D, Calabrese G, Min T, van Rhee F, Swansburg GJ, Dyer MJS, Maitland J, Palka G, Catovsky D Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9)(p23;q34). Leukemia. 9:1995;981-987.
27. Morris C, Kennedy M, Heisterkamp N, Columbano-Green L, Romeril K, Groffen J, Fitzgerald P A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Genes Chromosom Cancer. 3:1991;263-271.
28. Sessarego M, Fugazza G, Canepa L, Bacigalupo A, Bruzzone R, Patrone F Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. Leuk Res. 19:1995;921-925.
29. Wiedemann LM, Karhi KK, Shivji MKK, Rayter SI, Pegram SM, Dowden G, Bevan D, Will A, Galton DAG, Chan LC The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood. 71:1988;349-355.
30. Grossman A, Silver RT, Arlin Z, Coleman M, Camposano E, Cascon P, Benn PA Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for exon 3 in determining disease duration in chronic myeloid leukemia. Am J Hum Genet. 45:1989;729-735.
31. Mills KI, Benn P, Birni GD Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in CML? Blood. 78(5):1991;1155-1161.
32. Mills KI, Sproul AM, Leibowitz D, Burnett AK Mapping of breakpoints, and relationships to BCR-ABL RNA expression in Philadelphia chromosome CML patients with a breakpoint around exon 14(b3) of the bcr gene. Leukemia. 5:1994;937-941.
33. Elliot SL, Taylor KM, Taylor DL, Rodwell RL, Williams BF, Shuttlewood MM, Wright SJ, Eliadis PE, Bunce IH, Frost TJ, Olsen TE, Firkin F, Timms P Cytogenetic response to alpha interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location. Leukemia. 9:1995;946-950.